Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

SANUWAVE Health (SNWV) EBITDA Margin (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed EBITDA Margin for 8 consecutive years, with 3907.41% as the latest value for Q2 2025.

  • On a quarterly basis, EBITDA Margin fell 393522.0% to 3907.41% in Q2 2025 year-over-year; TTM through Sep 2025 was 86.37%, a 18157.0% increase, with the full-year FY2024 number at 16.6%, up 1925.0% from a year prior.
  • EBITDA Margin was 3907.41% for Q2 2025 at SANUWAVE Health, down from 10.55% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 44.53% in Q4 2024 to a low of 3907.41% in Q2 2025.